2020 Annual Meeting | C216 - Integrating Sleep Medicine Concepts into Your Child Neurology Practice

Date Thursday 04/30/20

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Suresh Kotagal, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology, Sleep

Learning Objectives Participants will review sleep-wake regulation; update their knowledge on primary hypersomnia disorders, diagnosis, and management; distiguish parasomnias from nocturnal seizures, their evaluation, overlap, and management; get highlights on key sleep-related management issues in autism, neurodegenerative disorders, and headache disorders using an interactive, case-based format.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM	Introduction	Introduction Suresh Kotagal, MD, FAAN
07:05 AM - 07:40 AM	Speaker	Update on Hypersomnia Disorders Kiran P. Maski, MD
07:40 AM - 08:20 AM	Speaker	Parasomnia Update Sanjeev V. Kothare, MD, FAAN
08:20 AM - 08:45 AM	Speaker	Interesting and Instructive Cases Suresh Kotagal, MD, FAAN
08:45 AM - 09:00 AM	Discussion	Panel Discussion Suresh Kotagal, MD, FAAN, Kiran P. Maski, MD

Faculty Disclosures
Suresh Kotagal, MD, FAAN	No disclosure on file
Kiran P. Maski, MD	An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
Sanjeev V. Kothare, MD, FAAN	Dr. Kothare has nothing to disclose.

��ɫ��

��ɫ��